The price of Relmada Therapeutics Inc (NASDAQ: RLMD) closed at $4.43 in the last session, down -17.41% from day before closing price of $5.37. In other words, the price has decreased by -$0.9350 from its previous closing price. On the day, 687571 shares were traded.
Ratios:
We take a closer look at RLMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.00 and its Current Ratio is at 8.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on October 14, 2022, Downgraded its rating to Hold and sets its target price to $10 from $90 previously.
Goldman Downgraded its Buy to Neutral on October 14, 2022, whereas the target price for the stock was revised from $81 to $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 31 ’24 when TRAVERSA SERGIO bought 27,460 shares for $4.00 per share. The transaction valued at 109,752 led to the insider holds 244,024 shares of the business.
Ence Chuck bought 13,670 shares of RLMD for $55,429 on Jan 31 ’24. The CA and CO now owns 38,970 shares after completing the transaction at $4.05 per share. On Jan 31 ’24, another insider, Shenouda Maged, who serves as the Chief Financial Officer of the company, bought 6,875 shares for $4.06 each. As a result, the insider paid 27,943 and bolstered with 34,903 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 133.82M and an Enterprise Value of 27.56M.
Stock Price History:
Over the past 52 weeks, RLMD has reached a high of $7.22, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is 4.9364, while the 200-Day Moving Average is calculated to be 3.4458.
Shares Statistics:
According to the various share statistics, RLMD traded on average about 315.75K shares per day over the past 3-months and 217.21k shares per day over the past 10 days. A total of 30.10M shares are outstanding, with a floating share count of 25.31M. Insiders hold about 15.90% of the company’s shares, while institutions hold 52.53% stake in the company. Shares short for RLMD as of Feb 29, 2024 were 1.75M with a Short Ratio of 5.56, compared to 1.61M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.83% and a Short% of Float of 5.93%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.97 for the current quarter, with a high estimate of -$0.96 and a low estimate of -$0.99, while EPS last year was -$0.87. The consensus estimate for the next quarter is -$0.78, with high estimates of -$0.56 and low estimates of -$1.01.
Analysts are recommending an EPS of between -$1.63 and -$3.94 for the fiscal current year, implying an average EPS of -$2.64. EPS for the following year is -$2.61, with 5 analysts recommending between -$1.26 and -$5.49.
